El-Beshlawy A - Search Results

1

Recent trends in treatment of thalassemia.

El-Beshlawy A, El-Ghamrawy M. El-Beshlawy A, et al. Blood Cells Mol Dis. 2019 May;76:53-58. doi: 10.1016/j.bcmd.2019.01.006. Epub 2019 Feb 4. Blood Cells Mol Dis. 2019. PMID: 30792169 Review.

2

Effect of L-carnitine on the physical fitness of thalassemic patients.

El-Beshlawy A, El Accaoui R, Abd El-Sattar M, Gamal El-Deen MH, Youssry I, Shaheen N, Hamdy M, El-Ghamrawy M, Taher A. El-Beshlawy A, et al. Ann Hematol. 2007 Jan;86(1):31-4. doi: 10.1007/s00277-006-0181-6. Epub 2006 Oct 10. Ann Hematol. 2007. PMID: 17031691 Clinical Trial.

3

Skin iron concentration: a simple, highly sensitive method for iron stores evaluation in thalassemia patients.

Youssry I, Mohsen NA, Shaker OG, El-Hennawy A, Fawzy R, Abu-Zeid NM, El-Beshlawy A. Youssry I, et al. Hemoglobin. 2007;31(3):357-65. doi: 10.1080/03630260701503833. Hemoglobin. 2007. PMID: 17654073

4

Fetal globin induction in beta-thalassemia.

El-Beshlawy A, Hamdy M, El Ghamrawy M. El-Beshlawy A, et al. Hemoglobin. 2009;33 Suppl 1:S197-203. doi: 10.3109/03630260903351882. Hemoglobin. 2009. PMID: 20001626 Review.

5

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD. Taher AT, et al. Blood. 2010 Mar 11;115(10):1886-92. doi: 10.1182/blood-2009-09-243154. Epub 2009 Dec 23. Blood. 2010. PMID: 20032507 Free article.

6

Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.

El Beshlawy A, El Tagui M, Hamdy M, El Ghamrawy M, Azim KA, Salem D, Said F, Samir A, St Pierre T, Pennell DJ. El Beshlawy A, et al. Ann Hematol. 2014 Mar;93(3):375-9. doi: 10.1007/s00277-013-1876-0. Epub 2013 Aug 15. Ann Hematol. 2014. PMID: 23949317

7

Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.

El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A. El-Beshlawy A, et al. Ann Hematol. 2014 Dec;93(12):2045-50. doi: 10.1007/s00277-014-2154-5. Epub 2014 Jul 27. Ann Hematol. 2014. PMID: 25062719

8

Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.

Aboul-Enein A, El-Beshlawy A, Hamdy M, Shaheen I, El-Saadany Z, Samir A, El-Samie HA. Aboul-Enein A, et al. Gene. 2015 Jun 15;564(2):206-9. doi: 10.1016/j.gene.2015.03.048. Epub 2015 Mar 25. Gene. 2015. PMID: 25816754

9

Erratum to: Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.

El-Beshlawy A, El-Ghamrawy M, El-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A. El-Beshlawy A, et al. Ann Hematol. 2016 Apr;95(5):851. doi: 10.1007/s00277-016-2635-9. Ann Hematol. 2016. PMID: 26972109 No abstract available.

10

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study.

Kwiatkowski JL, Hamdy M, El-Beshlawy A, Ebeid FSE, Badr M, Alshehri A, Kanter J, Inusa B, Adly AAM, Williams S, Kilinc Y, Lee D, Tricta F, Elalfy MS. Kwiatkowski JL, et al. Blood Adv. 2022 Feb 22;6(4):1243-1254. doi: 10.1182/bloodadvances.2021004938. Blood Adv. 2022. PMID: 34847228 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters